Beryl Drugs Ltd - BERYL DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE415H01017

Beryl Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/24/2024 12:00:00 AM

    ₹ 34.7 -0.03 -0.09
  • Open
  • ₹ 36.4
  • Prev. Close
  • ₹ 34.73
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 36.4
  • Day's Low
  • ₹ 33.21
  • 52 Week's High
  • ₹ 44.98
  • 52 Week's Low
  • ₹ 12.51
  • Book Value
  • ₹ 17.734
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 17.6
  • P/E
  • 14.96
  • EPS
  • 2.32
  • Divi. Yield
  • 0

Beryl Drugs Ltd Corporate Actions

12 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2024

12:00 AM

31 Oct , 2023

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Aug , 2023

12:00 AM

AGM

Announcement date: 25 Aug , 2023

View Details

17 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

18 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Beryl Drugs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT
25 April , 2024 | 06:24 AM

PROMOTER - TOTAL26.38%

Indian: 26.38%

Foreign: 0%

NON-PROMOTER - TOTAL 73.62%

Institutions: 0.00%

Non-Institutions: 73.62%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Beryl Drugs Ltd FINANCIALS

No Data Available To Display Chart

Beryl Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Beryl Drugs Ltd

  • Sanjay Sethi
  • ED / MD / Promoter
  • Sudhir Sethi
  • Chairman & Non Executive Dir.
  • Abhinav Naik
  • Independent Non Exe. Director
  • Shreya Saraf
  • Independent Non Exe. Director

Summary

Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare... Read More


Reports by Beryl Drugs Ltd


Reports by Beryl Drugs Ltd

Company FAQ

No Record Found